Bottom line
How much do FBTAX and FBDIX overlap?
38% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 34.4% of FBTAX's assets and 30.4% of FBDIX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBTAX and FBDIX have in common
| Holding | % of FBTAX | % of FBDIX | Overlap |
|---|---|---|---|
| Gilead Sciences Inc | 5.70% | 3.86% | 3.86% |
| Spyre Therapeutics Inc | 3.83% | 1.87% | 1.87% |
| Dianthus Therapeutics Inc | 3.55% | 2.32% | 2.32% |
| Oruka Therapeutics Inc | 3.24% | 1.86% | 1.86% |
| Insmed Inc | 3.05% | 1.99% | 1.99% |
| Revolution Medicines Inc | 3.00% | 3.01% | 3.00% |
| Argenx Se | 3.00% | 3.62% | 3.00% |
| Ascendis Pharma A/s | 2.99% | 2.56% | 2.56% |
| Amgen Inc | 2.37% | 4.39% | 2.37% |
| Amylyx Pharmaceuticals Inc | 2.25% | 1.32% | 1.32% |
| Vertex Pharmaceuticals Inc | 1.39% | 3.54% | 1.39% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBTAX
- Abbvie Inc — 14.71%
- Alnylam Pharmaceuticals Inc — 3.62%
- Cogent Biosciences Inc — 3.25%
- Biogen Inc — 2.71%
- Mbx Biosciences Inc — 2.45%
- Vaxcyte Inc — 1.97%
- Fidelity Revere Street Trust — 1.96%
- Moderna Inc — 1.60%
- Relay Therapeutics Inc — 1.58%
- Viridian Therapeutics Inc — 1.53%
- Natera Inc — 1.43%
- Kiniksa Pharmaceuticals International Plc — 1.41%
- Enliven Therapeutics Inc — 1.25%
- Alumis Inc — 1.22%
Only in FBDIX
- Jazz Pharmaceuticals plc — 5.66%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Guardant Health, Inc. — 2.76%
- Mirum Pharmaceuticals, Inc. — 1.98%
- Praxis Precision Medicines, Inc. — 1.91%
- Neurocrine Biosciences, Inc. — 1.82%
- Bridgebio Pharma, Inc. — 1.67%
- PTC Therapeutics, Inc. — 1.65%
- AstraZeneca plc — 1.51%
- Franklin Institutional U.S. Government Money Market Fund — 1.45%
- Eli Lilly & Co. — 1.31%
- Cytokinetics, Inc. — 1.24%
- Tango Therapeutics, Inc. — 1.23%
Asset mix
| Asset type | FBTAX | FBDIX |
|---|---|---|
| Stocks | 98.2% | 97.0% |
| Cash & short-term funds | 2.4% | 4.6% |
| Preferred stock | 1.5% | 1.0% |
| Other | — | 0.6% |
| Bonds | 0.1% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | FBTAX | FBDIX |
|---|---|---|
| US | 87.8% | 82.0% |
| IE | — | 6.7% |
| NL | 4.3% | 4.5% |
| DK | 3.0% | 2.6% |
| KY | 1.8% | 0.7% |
| GB | 1.8% | 1.5% |
| FR | 0.4% | 1.7% |
| CA | 1.4% | 1.3% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FBTAX and FBDIX overlap?
What stocks do FBTAX and FBDIX have in common?
Should I own both FBTAX and FBDIX?
Which holds more stocks, FBTAX or FBDIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.